UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[News Focus] Abbvie hits back at competitors selling Humira biosimilars in Europe
by Lee Han-soo
2019-04-15 15:19
All Invossa products contained 293 cells, Kolon confirms
by Jeong Sae-im
2019-04-15 11:31
Invossa license won’t be revoked: Kolon CEO
by Jeong Sae-im
2019-04-12 11:40
Regulator, Kolon rebuked for slow response to Invossa problem
by Jeong Sae-im
2019-04-11 14:46
Canada OKs Celltrion’s Truxima
by Lee Han-soo
2019-04-11 11:33
라인
Patients may file class-action lawsuit against Kolon for mislabeling Invossa
by Jeong Sae-im
2019-04-10 14:41
Celltrion, iProgen to co-develop novel antibody-drug conjugates
by Lee Han-soo
2019-04-09 16:04
Kolon’s foreign partners await cell analysis results
by Jeong Sae-im
2019-04-08 14:28
Kolon Life Science criticized for poor quality control on Invossa
by Jeong Sae-im
2019-04-05 12:27
‘Invossa, first treatment to have used cancerous cell lines’
by Jeong Sae-im
2019-04-04 15:24
라인
Celltrion completes patient registration for Humira biosimilar
by Lee Han-soo
2019-03-28 18:04
Alteogen wins patent on SC injection formulation for Herceptin biosimilar
by Lee Han-soo
2019-03-28 15:04
GC’s US branch opens new plasma collection centers
by Lee Han-soo
2019-03-27 10:43
Celltrion licenses out hypertrophic cardiomyopathy treatment to Japan
by Lee Han-soo
2019-03-25 15:41
Regulator OKs Medipost’s P1 trial of knee osteoarthritis treatment
by Lee Han-soo
2019-03-22 14:22
라인
Samsung Bioepis unveils 3-year follow-up data for Ontruzant
by Lee Han-soo
2019-03-22 14:05
'US sales of Truxima imminent'
by Jeong Sae-im
2019-03-20 17:59
Samsung BioLogics, Eutilex to develop anti-cancer immunotherapies
by Lee Han-soo
2019-03-20 17:18
Samsung Bioepis nullifies patents related to Herceptin in Korea
by Lee Han-soo
2019-03-18 15:51
Thea, OliX to cooperate in developing age-related macular degeneration treatment
by Lee Han-soo
2019-03-18 12:02
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top